Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2011-10-13 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LONLAY-L'ABBAYE (61700), Orne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE BINET V : revenue, balance sheet and financial ratios
SELARL PHARMACIE BINET V is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LONLAY-L'ABBAYE (61700),
this company of category PME
shows in 2025 a net income positive of 66 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE BINET V (SIREN 535287072)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
66 432 €
81 202 €
60 645 €
123 051 €
64 758 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE BINET V generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 65 k€ -> 66 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
66 432 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
41.004%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.691%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE BINET V
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
162.268
100.242
73.7
51.625
41.004
Financial autonomy
33.84
45.741
53.034
59.926
65.691
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
41.02025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-8 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE BINET V (41.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.69%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+11 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE BINET V (65.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 233.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
233.104
Liquidity indicators evolution SELARL PHARMACIE BINET V
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
2024
2025
Liquidity ratio
158.576
204.153
216.677
204.632
233.104
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
233.12025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+8 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE BINET V (233.10) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELARL PHARMACIE BINET V in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE BINET V is estimated at
1 055 280 €
(range 716 118€ - 1 655 879€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
716k€1055k€1655k€
1 055 280 €Range: 716 118€ - 1 655 879€
NAF 5 année 2025
Valuation method used
Net Income Multiple
66 432 €
×
15.9x
=1 055 280 €
Range: 716 118€ - 1 655 880€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE BINET V with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE BINET V
What is the revenue of SELARL PHARMACIE BINET V ?
The revenue of SELARL PHARMACIE BINET V is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE BINET V profitable?
Yes, SELARL PHARMACIE BINET V generated a net profit of 66 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE BINET V ?
The headquarters of SELARL PHARMACIE BINET V is located in LONLAY-L'ABBAYE (61700), in the department Orne.
Where to find the tax return of SELARL PHARMACIE BINET V ?
The tax return of SELARL PHARMACIE BINET V is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE BINET V operate?
SELARL PHARMACIE BINET V operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart